Design, synthesis, and docking analysis of benzene sulfonamide-[1,4]benzoxazepine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors

= 4.18 ± 0.56 µM; SI = 14.94). Molecular docking studies revealed plausible binding modes of the active compounds within the AChE and BChE active sites, involving π-π stacking, hydrogen bonding, and hydrophobic interactions. The SAR analysis indicated that the effects of nitro and halogen substituents were scaffold- and position-dependent, with selected nitro-substituted derivatives showing enhanced cholinesterase inhibition, whereas brominated analogs exhibited a pronounced preference toward BChE. Integration of the biological and computational data identified compounds 9a, 9b, 9d, 12b, 12j, and 12j as promising candidates for further investigation. Among these, 12j represents the potency lead for BChE inhibition, whereas 9d provides the most pronounced BChE selectivity. ADMET predictions further suggested more favorable physicochemical and pharmacokinetic profiles for selected benzoxazepine-based derivatives, although potential toxicity liabilities were predicted for 12j. Overall, these findings support the [1,4]benzoxazepine-sulfonamide scaffold as a promising starting point for developing BChE-preferring cholinesterase inhibitors.

Authors

Institutions

Publication Details

Journal
RSC Advances
Published
2026-11-18
DOI
https://doi.org/10.1039/d6ra08312a
Primary Topic
Cholinesterase and Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Design, synthesis, and docking analysis of benzene sulfonamide-[1,4]benzoxazepine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors

Murad A. AlDamen, Mahmoud A. Al-Sha’er, Almeqdad Y. Habashneh, Wafa Hourani et al.
2 links
RSC Advances
Cholinesterase and Neurodegenerative Diseases
article

Design, synthesis, and docking analysis of benzene sulfonamide-[1,4]benzoxazepine hybrids as acetylcholinesterase and butyrylcholinesterase inhibitors

Murad A. AlDamen, Mahmoud A. Al-Sha’er, Almeqdad Y. Habashneh, Wafa Hourani, Muhammad Ashram
article en

Abstract

= 4.18 ± 0.56 µM; SI = 14.94). Molecular docking studies revealed plausible binding modes of the active compounds within the AChE and BChE active sites, involving π-π stacking, hydrogen bonding, and hydrophobic interactions. The SAR analysis indicated that the effects of nitro and halogen substituents were scaffold- and position-dependent, with selected nitro-substituted derivatives showing enhanced cholinesterase inhibition, whereas brominated analogs exhibited a pronounced preference toward BChE. Integration of the biological and computational data identified compounds 9a, 9b, 9d, 12b, 12j, and 12j as promising candidates for further investigation. Among these, 12j represents the potency lead for BChE inhibition, whereas 9d provides the most pronounced BChE selectivity. ADMET predictions further suggested more favorable physicochemical and pharmacokinetic profiles for selected benzoxazepine-based derivatives, although potential toxicity liabilities were predicted for 12j. Overall, these findings support the [1,4]benzoxazepine-sulfonamide scaffold as a promising starting point for developing BChE-preferring cholinesterase inhibitors.

RSC AdvancesVol. 16(50)
University of Jordan (JO), Zarqa University (JO), Philadelphia University (JO), Mutah University (JO)
University of Jordan, Zarqa University
Cholinesterase and Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon